Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer

Published:2018-11-09 Issue:2 Volume:22 Page:324-330
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Weisman Amy J.,Harmon Stephanie A.,Perk Timothy G.^ORCID,Eickhoff Jens,Choyke Peter L.,Kurdziel Karen A.,Dahut William L.,Humm John L.,Apolo Andrea B.,Larson Steven M.,Morris Michael J.^ORCID,Perlman Scott B.,Liu Glenn,Jeraj Robert

Funder

Prostate Cancer Foundation

University of Wisconsin Carbone Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0110-5.pdf

Reference20 articles.

1. Ryan CJ, Shah S, Eleni E, Smith MR, Taplin M-E, Bubley GJ, et al. Phase II Study of Abiraterone Acetate Plus Prednisone in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Demonstrating Radiographic Flare Discordant With Serologic Measures of Response. Clin Cancer Res. 2011;17:4854–61.

2. Armstrong AJ, Kaboteh R, Carducci MA, Damber JE, Stadler WM, Hansen M, et al. Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC). Urol Oncol. 2014;32:1308–16.

3. O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: an update. World J Radiol. 2015;7:202–11.

4. Bauerle T, Semmler W. Imaging response to systemic therapy for bone metastases. Eur Radiol. 2009;19:2495–507.

5. Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, et al. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016;34:1402–18.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer;Annals of Nuclear Medicine;2024-03-13

2. Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?;Frontiers in Medicine;2024-01-15

3. Predicting Fractures Using Vertebral 18F-NaF Uptake in Prostate Cancer Patients;Journal of Bone Metabolism;2023-11-30

4. Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate;Médecine Nucléaire;2023-10

5. Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report;Frontiers in Oncology;2023-01-04